A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

计划入组 557 人 · 首次发布于 2024 年 1 月 22 日

Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell

计划入组 16 人 · 首次发布于 2008 年 4 月 10 日

Real World Data on Ibrutinib Use in PCNSL Rel/Ref

计划入组 36 人 · 首次发布于 2023 年 3 月 23 日

TML-REF-18

1-naphthaleneacetic acid

C₁₂H₁₀O₂

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Opus Genetics Gains FDA Agreement for Phase 3 Trial of APX3330 in Diabetic Retinopathy

Ocuphire Pharma Acquires Opus Genetics, Expanding Gene Therapy Pipeline for Inherited Retinal Diseases

Cardurion Completes Enrollment in Phase 2 Trials for Novel Heart Failure Drug CRD-750